Form 8-K NPS PHARMACEUTICALS INC For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
NPS Pharmaceuticals, Inc. (NPSP) Tops Q2 EPS by 2c
August 6, 2014 5:00 PM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q2 EPS of $0.02, $0.02 better than the analyst estimate of $0.00. Revenue for the quarter came in at $56.13 million versus the consensus estimate of $53.06 million.
For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.
... More


